Boston Scientific (BSX)
(Delayed Data from NYSE)
$72.91 USD
+3.92 (5.68%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $73.06 +0.15 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
BSX 72.91 +3.92(5.68%)
Will BSX be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for BSX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BSX
Boston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
AHCO vs. BSX: Which Stock Is the Better Value Option?
BSX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Boston Scientific (BSX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates
What's in Store for These 4 Medical Products Stocks in Q1 Earnings?
Other News for BSX
Boston Scientific price target raised by $13 at Stifel, here's why
Treasury Yields Rise, Tesla Jumps On Cheaper Model Pledge, Yen Plummets To 34-Year Lows: What's Driving Markets Wednesday?
Texas Instruments, Mattel rise; General Dynamics, Teledyne fall, Wednesday, 4/24/2024
Boston Scientific’s stock heads for record high as earnings shine and company offers upbeat guidance
Boston Scientific hits 52-week high on Q1 beat